Sarcopenia: Prevention, Treatment & Impact on Healthy Aging
The global rise in longevity presents a significant public health challenge: maintaining quality of life in older age. A growing body of research identifies sarcopenia – the progressive loss of muscle mass and strength – as a key factor impacting healthy aging, increasing risks of falls, fractures, cognitive decline, and mortality. While often dismissed as an inevitable consequence of aging, experts now emphasize that sarcopenia is a preventable and treatable condition.
Defined in 1988 by researcher Rosenberg as a clinical condition characterized by loss of skeletal muscle mass, sarcopenia is increasingly understood as a complex geriatric syndrome. According to a recent review published in Nefrología, the condition can lead to an annual loss of muscle mass of 2-3% after the ages of 50 and 65. The European Working Group on Sarcopenia in Older People (EWGSOP) has developed diagnostic algorithms, like EWGSOP2, to identify individuals at risk, assessing muscle strength, mass, and physical performance. However, implementation of these tools faces challenges, including limited accessibility of assessment techniques and a tendency to normalize age-related strength loss.
A study published in Nutrients in 2022, examining hemodialysis patients over 75, found a high prevalence of probable sarcopenia – ranging from 75% to 97% depending on the criteria used. Importantly, the study demonstrated a correlation between confirmed and severe sarcopenia, as measured by appendicular skeletal muscle mass and gait speed, and an increased risk of all-cause mortality, with hazard ratios of 3.03 and 3.29 respectively. This underscores the clinical significance of accurate diagnosis and intervention.
Experts agree that a combination of resistance exercise and adequate nutrition is crucial in preventing and managing sarcopenia. Research indicates that strength and resistance training programs can significantly improve and preserve muscle mass and functionality. At least two strength training sessions per week are recommended to achieve sustained benefits, with a dose-response relationship suggesting greater activity leads to greater muscle gain. Dietary intake, particularly protein, is equally important, counteracting age-related anorexia, malnutrition, and dehydration that contribute to muscle loss.
However, the development of sarcopenia is often complicated by underlying chronic conditions. In Mexico, diabetes mellitus type 2 affects 36.1% of individuals over 60, according to the ENSANUT 2021-2024 survey. This metabolic disorder triggers a process of proteolysis, where the body breaks down muscle tissue for energy. Similarly, chronic kidney disease induces metabolic changes that promote muscle degradation. These comorbidities significantly contribute to the development of sarcopenia and diminished quality of life.
Researchers are now advocating for a shift in perspective, viewing sarcopenia not as an unavoidable aspect of aging, but as a condition requiring proactive management. Early detection and intervention, alongside addressing underlying health issues like diabetes and kidney disease, are essential. Further research is needed to validate diagnostic algorithms like EWGSOP2 in diverse clinical settings and to develop accessible and reliable assessment tools for routine care.